Compound ID | 72
Class: Bacteriophage lysin
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) |
| Institute where first reported: | Department of Ophthalmology and Kresge Eye Institute, Wayne State University, Detroit, Michigan, USA |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citations: |
|